Cited by 6,873HIV/AIDS Research and InterventionsHIV Research and TreatmentHIV/AIDS drug development and treatment

The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.

Prevention of HIV-1 infection with early antiretroviral therapy.

Open access

Cohen, Myron S., Chen, Ying Q., McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C., Kumarasamy, Nagalingeswaran, Hakim, James G., Kumwenda, Johnstone, Grinsztejn, Beatriz, Pilotto, Jose H.S., Godbole, Sheela V., Mehendale, Sanjay, Chariyalertsak, Suwat, Santos, Breno R., Mayer, Kenneth H., Hoffman, Irving F., Eshleman, Susan H., Piwowar-Manning, Estelle, Wang, Lei, Makhema, Joseph, Mills, Lisa A., de Bruyn, Guy, Sanne, Ian, Eron, Joseph, Gallant, Joel, Havlir, Diane, Swindells, Susan, Ribaudo, Heather, Elharrar, Vanessa, Burns, David, Taha, Taha E., Nielsen-Saines, Karin, Celentano, David, Essex, Max, Fleming, Thomas R.·2011·New England Journal of Medicine

DOI 10.1056/nejmoa1105243PMC PMC3200068

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. METHODS: In nine countries, we enrolled 1763 couples in which one partner was HIV-1-positive and the other was HIV-1-negative; 54% of the subjects were from Africa, and 50% of infected partners were men. HIV-1-infected subjects with CD4 counts between 350 and 550 cells per cubic millimeter were randomly assigned in a 1:1 ratio to receive antiretroviral therapy either immediately (early therapy) or after a decline in the CD4 count or the onset of HIV-1-related symptoms (delayed therapy). The primary prevention end point was linked HIV-1 transmission in HIV-1-negative partners. The primary clinical end point was the earliest occurrence of pulmonary tuberculosis, severe bacterial infection, a World Health Organization stage 4 event, or death. RESULTS: As of February 21, 2011, a total of 39 HIV-1 transmissions were observed (incidence rate, 1.2 per 100 person-years; 95% confidence interval [CI], 0.9 to 1.7); of these, 28 were virologically linked to the infected partner (incidence rate, 0.9 per 100 person-years, 95% CI, 0.6 to 1.3). Of the 28 linked transmissions, only 1 occurred in the early-therapy group (hazard ratio, 0.04; 95% CI, 0.01 to 0.27; P<0.001). Subjects receiving early therapy had fewer treatment end points (hazard ratio, 0.59; 95% CI, 0.40 to 0.88; P=0.01). CONCLUSIONS: The early initiation of antiretroviral therapy reduced rates of sexual transmission of HIV-1 and clinical events, indicating both personal and public health benefits from such therapy. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 052 ClinicalTrials.gov number, NCT00074581.).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa1105243

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Self-citation
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
Quinn, T. C., Wawer, M. J., Sewankambo, N. K., Serwadda, D., Li, C., Wabwire‐Mangen, F., Meehan, M. O., Lutalo, T., & Gray, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421303 · Cited by 2,990
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
Granich, R., Gilks, C. F., Dye, C., Cock, K. M. D., & Williams, B. G. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61697-9 · Cited by 1,987
Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda.
Wawer, M. J., Gray, R. H., Sewankambo, N. K., Serwadda, D., Li, X., Laeyendecker, O., Kiwanuka, N., Kigozi, G., Kiddugavu, M., Lutalo, T., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/429411 · Cited by 1,258
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries
Braitstein, P. K. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68337-2 · Cited by 1,106
Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival
Kitahata, M. M., Gange, S. J., Abraham, A. G., Merriman, B., Saag, M. S., Justice, A. C., Hogg, R. S., Deeks, S. G., Eron, J. J., Brooks, J. T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807252 · Cited by 1,105
Self-citation
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
Donnell, D. J., Baeten, J. M., Kiarie, J. N., Thomas, K. K., Stevens, W. S., Cohen, C. R., McIntyre, J. A., Lingappa, J. R., & Celum, C. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60705-2 · Cited by 970
Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study
Montaner, J. S., Lima, V. D., Barrios, R., Yip, B., Wood, E., Kerr, T., Shannon, K., Harrigan, P. R., Hogg, R. S., Daly, P., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60936-1 · Cited by 780
Decreases in Community Viral Load Are Accompanied by Reductions in New HIV Infections in San Francisco
Das, M., Chu, P. L., Santos, G., Scheer, S., Vittinghoff, E., McFarland, W., & Colfax, G. N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011068 · Cited by 771
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies
Sterne, J. A. C. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60612-7 · Cited by 748

Flagged first, then by citations

Show all 35 references

Research works printed but not linked: 1

Smith K, 2011, Curr Opin HIV AIDS, 6, 315

Sorted by citations

Code Saturation Versus Meaning Saturation: How Many Interviews Are Enough?
Hennink, M. M., Kaiser, B. N., & Marconi, V. C. (2017) · Qualitative Health Research · doi:10.1177/1049732316665344 · Cited by 4,597
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Sexually Transmitted Infections Treatment Guidelines, 2021
Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, C. A., Park, I., Reno, H., Zenilman, J. M., & Bolan, G. A. (2021) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr7004a1 · Cited by 3,018
Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
The INSIGHT START Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506816 · Cited by 2,803
Sexually Transmitted Diseases Treatment Guidelines, 2010
Workowski, K., & BOLAN, G. A. (2011) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.04.006 · Cited by 2,074
Antiretroviral therapy for the prevention of HIV-1 transmission.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1600693 · Cited by 1,700
Self-citation
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C. L., Gall, J.-M. L., Cua, É., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,698
Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy.
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.5148 · Cited by 1,431
Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada
Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K. A., Burchell, A. N., Cohen, M. H., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,420
Self-citation
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
The TEMPRANO ANRS 12136 Study Group (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1507198 · Cited by 1,246
South African National HIV Prevalence, Incidence and Behaviour Survey, 2012
Shisana, O., Rehle, T. M., Simbayi, L. C., Zuma, K. K., Jooste, S., Zungu, N. P., Labadarios, D., & Onoya, D. (2014) · Cited by 1,187
Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis
Baral, S., Beyrer, C., Muessig, K. E., Poteat, T., Wirtz, A. L., Decker, M. R., Sherman, S. G., & Kerrigan, D. L. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70066-x · Cited by 1,186
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., Degen, O., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30418-0 · Cited by 1,023
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Sáez‐Cirión, A., Bacchus, C., Hocqueloux, L., Avettand-Fènoël, V., Girault, I., Lécuroux, C., Potard, V., Versmisse, P., Mélard, A., Prazuck, T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003211 · Cited by 1,012
HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities
Kharsany, A. B. M., & Karim, Q. A. (2016) · The Open AIDS Journal · doi:10.2174/1874613601610010034 · Cited by 1,041
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Maartens, G., Celum, C., & Lewin, S. R. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60164-1 · Cited by 913
High Coverage of ART Associated with Decline in Risk of HIV Acquisition in Rural KwaZulu-Natal, South Africa
Tanser, F. C., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M. (2013) · Science · doi:10.1126/science.1228160 · Cited by 797
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable
Eisinger, R. W., Dieffenbach, C. W., & Fauci, A. S. (2019) · JAMA · doi:10.1001/jama.2018.21167 · Cited by 753
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission
Bekker, L., Alleyne, G. A. O., Baral, S., Cepeda, J., Daskalakis, D., Dowdy, D. W., Dybul, M. R., Eholié, S. P., Esom, K., Garnett, G. P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31070-5 · Cited by 793
Self-citation
Sexually transmitted infections: challenges ahead
Unemo, M., Bradshaw, C. S., Hocking, J. S., de Vries, H. J. C., Francis, S. C., Mabey, D. C. W., Marrazzo, J. M., Sonder, G. J. B., Schwebke, J. R., Hoornenborg, E., et al. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30310-9 · Cited by 776
Estimating per-act HIV transmission risk: a systematic review
Patel, P., Borkowf, C. B., Brooks, J. T., Lasry, A., Lansky, A., & Mermin, J. (2014) · AIDS · doi:10.1097/qad.0000000000000298 · Cited by 748
Comparisons of disparities and risks of HIV infection in black and other men who have sex with men in Canada, UK, and USA: a meta-analysis
Millett, G. A., Peterson, J. L., Flores, S. A., Hart, T. A., Jeffries, W. L., Wilson, P. A., Rourke, S. B., Heilig, C. M., Elford, J., Fenton, K. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60899-x · Cited by 724
Modeling infectious disease dynamics in the complex landscape of global health
Heesterbeek, H., Anderson, R. M., Andreasen, V., Bansal, S., Angelis, D. D., Dye, C., Eames, K. T. D., Edmunds, W. J., Frost, S. D. W., Funk, S., et al. (2015) · Science · doi:10.1126/science.aaa4339 · Cited by 721
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults
Günthard, H. F., Saag, M. S., Benson, C. A., del Rı́o, C., Eron, J. J., Gallant, J. E., Hoy, J., Mugavero, M. J., Sax, P. E., Thompson, M., et al. (2016) · JAMA · doi:10.1001/jama.2016.8900 · Cited by 740
Self-citation
HIV infection
Deeks, S. G., Overbaugh, J. M., Phillips, A. N., & Buchbinder, S. P. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.35 · Cited by 718
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
Hammer, S. M., Sobieszczyk, M. E., Janes, H., Karuna, S., Mulligan, M. J., Grove, D., Koblin, B. A., Buchbinder, S., Keefer, M. C., Tomaras, G. D., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1310566 · Cited by 618
Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy
May, M., Gompels, M. M., Delpech, V., Porter, K., Orkin, C. M., Kegg, S., Hay, P., Johnson, M. A., Palfreeman, A., Gilson, R. J. C., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000243 · Cited by 621
Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV: Evidence-Based Recommendations From an International Association of Physicians in AIDS Care Panel
Thompson, M., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 585
Humanized Mouse Models of Clinical Disease
Walsh, N. C., Kenney, L. L., Jangalwe, S., Aryee, K., Greiner, D. L., Brehm, M. A., & Shultz, L. D. (2016) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-052016-100332 · Cited by 585
Towards an HIV cure: a global scientific strategy
The International AIDS Society Scientific Working Group on HIV Cure (2012) · Nature reviews. Immunology · doi:10.1038/nri3262 · Cited by 575
Human Immunodeficiency Virus Transmission at Each Step of the Care Continuum in the United States
Skarbinski, J., Rosenberg, E. S., Paz‐Bailey, G., Hall, H. I., Rose, C. E., Viall, A. H., Fagan, J. L., Lansky, A., & Mermin, J. (2015) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.8180 · Cited by 551
Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study.
Bavinton, B. R., Pinto, A. N., Phanuphak, N., Grinsztejn, B., Prestage, G. P., Zablotska-Manos, I. B., Jin, F., Fairley, C. K., Moore, R., Roth, N., et al. (2018) · The Lancet HIV · doi:10.1016/s2352-3018(18)30132-2 · Cited by 524
Self-citation
Birth–death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV)
Stadler, T., Kühnert, D., Bonhoeffer, S., & Drummond, A. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207965110 · Cited by 528
The State of Engagement in HIV Care in the United States: From Cascade to Continuum to Control
Mugavero, M. J., Amico, K. R., Horn, T., & Thompson, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit420 · Cited by 509
Stigma and racial/ethnic HIV disparities: Moving toward resilience.
Earnshaw, V. A., Bogart, L. M., Dovidio, J. F., & Williams, D. R. (2013) · American Psychologist · doi:10.1037/a0032705 · Cited by 531
Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Aberg, J. A., Gallant, J. E., Ghanem, K. G., Emmanuel, P. J., Zingman, B. S., & Horberg, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit665 · Cited by 501
Self-citation
Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial
Grinsztejn, B. G. J., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J. J., Chen, Y. Q., Wang, L., Ou, S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Self-citation
Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals
Martin, N. K., Vickerman, P. T., Grebely, J., Hellard, M. E., Hutchinson, S. J., Lima, V. D., Foster, G. R., Dillon, J. F., Goldberg, D. J., Dore, G. J., et al. (2013) · Hepatology · doi:10.1002/hep.26431 · Cited by 488
Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries
Nachega, J. B., Uthman, O. A., Anderson, J., Peltzer, K., Wampold, S., Cotton, M. F., Mills, E. J., Ho, Y., Stringer, J. S. A., McIntyre, J. A., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328359590f · Cited by 501
Adherence to antiretroviral therapy in adolescents living with HIV
Kim, S.-H., Gerver, S. M., Fidler, S. J., & Ward, H. (2014) · AIDS · doi:10.1097/qad.0000000000000316 · Cited by 432
Depression and Adherence to Antiretroviral Therapy in Low-, Middle- and High-Income Countries: A Systematic Review and Meta-Analysis
Uthman, O. A., Magidson, J. F., Safren, S. A., & Nachega, J. B. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0220-1 · Cited by 466
HIV and Inflammation: Mechanisms and Consequences
Hunt, P. W. (2012) · Current HIV/AIDS Reports · doi:10.1007/s11904-012-0118-8 · Cited by 431
Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis
Suthar, A. B., Lawn, S. D., del Amo, J., Getahun, H., Dye, C., Sculier, D., Sterling, T. R., Chaisson, R. E., Williams, B. G., Harries, A. D., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001270 · Cited by 397
The Role of Stigma and Medical Mistrust in the Routine Health Care Engagement of Black Men Who Have Sex With Men
Eaton, L. A., Driffin, D. D., Kegler, C., Smith, H., Conway-Washington, C., White, D., & Cherry, C. (2014) · American Journal of Public Health · doi:10.2105/ajph.2014.302322 · Cited by 415
Vital Signs: HIV diagnosis, care, and treatment among persons living with HIV--United States, 2011.
Bradley, H. M., Hall, H. I., Wolitski, R. J., Handel, M. M. V., Stone, A. E., LaFlam, M., Skarbinski, J., Higa, D. H., Prejean, J., Frazier, E. L., et al. (2014) · PubMed Central · Cited by 397
The Adolescent and Young Adult HIV Cascade of Care in the United States: Exaggerated Health Disparities
Zanoni, B. C., & Mayer, K. H. (2014) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0345 · Cited by 402
Self-citation
HIV Treatment as Prevention: Systematic Comparison of Mathematical Models of the Potential Impact of Antiretroviral Therapy on HIV Incidence in South Africa
Eaton, J. W., Johnson, L. F., Salomon, J. A., Bärnighausen, T., Bendavid, E., Bershteyn, A., Bloom, D. E., Cambiano, V., Fraser, C., Hontelez, J. A. C., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001245 · Cited by 395
Screening for HIV: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-1-201307020-00645 · Cited by 393
Technologies for global health
Howitt, P. J., Darzi, A. W., Yang, G., Ashrafian, H., Atun, R. A., Barlow, J. G., Blakemore, A. I. F., Bull, A. M. J., Car, J., Conteh, L., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61127-1 · Cited by 384
Successes and challenges of HIV prevention in men who have sex with men
Sullivan, P. S., Carballo‐Diéguez, A., Coates, T. J., Goodreau, S. M., McGowan, I., Sanders, E. J., Smith, A. D., Goswami, P., & Sánchez, J. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60955-6 · Cited by 385
Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples
Cohen, C. R., Lingappa, J. R., Baeten, J. M., Ngayo, M. O., Spiegel, C. A., Hong, T., Donnell, D. J., Celum, C., Kapiga, S., Delany‐Moretlwe, S., et al. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001251 · Cited by 389
Global Update on HIV Treatment 2013: Results, Impact and Opportunities
Weiler, G. (2013) · Cited by 374
HIV risk and preventive interventions in transgender women sex workers
Poteat, T., Wirtz, A. L., Radix, A., Borquez, A., Silva-Santisteban, A., Deutsch, M. B., Khan, S. I., Winter, S., & Operario, D. (2015) · The Lancet · doi:10.1016/s0140-6736(14)60833-3 · Cited by 359
Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
Tenthani, L., Haas, A. D., Tweya, H. M., Jahn, A., van Oosterhout, J. J., Chimbwandira, F. M., Chirwa, Z., Ng’ambi, W. F., Bakali, A., Phiri, S., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000143 · Cited by 379
After 2015: infectious diseases in a new era of health and development
Dye, C. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0426 · Cited by 362
Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
Montaner, J. S. G., Lima, V. D., Harrigan, P. R., Lourenço, L., Yip, B., Nosyk, B., Wood, E., Kerr, T. H., Shannon, K., Moore, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087872 · Cited by 354
The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future
Kay, E. S., Batey, D. S., & Mugavero, M. J. (2016) · AIDS Research and Therapy · doi:10.1186/s12981-016-0120-0 · Cited by 333
The increase in global HIV epidemics in MSM
Beyrer, C., Sullivan, P. S., Sánchez, J., Baral, S., Collins, C., Wirtz, A. L., Altman, D., Trapence, G., & Mayer, K. H. (2013) · AIDS · doi:10.1097/01.aids.0000432449.30239.fe · Cited by 350
Self-citation
Women and HIV in Sub-Saharan Africa
Gita Ramjee, H., & Daniels, B. B. (2013) · AIDS Research and Therapy · doi:10.1186/1742-6405-10-30 · Cited by 343
Current status and prospects of HIV treatment
Cihlář, T., & Fordyce, M. W. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 352
Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)
Hayes, R., Donnell, D. J., Floyd, S., Mandla, N., Bwalya, J., Sabapathy, K., Yang, B., Phiri, M. M., Schaap, A., Eshleman, S. H., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1814556 · Cited by 334
Self-citation
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Barouch, D. H., Tomaka, F. L., Wegmann, F., Stieh, D. J., Alter, G., Robb, M. L., Michael, N. L., Peter, L. E., Nkolola, J. P., Borducchi, E. N., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31364-3 · Cited by 340
Uptake, Accuracy, Safety, and Linkage into Care over Two Years of Promoting Annual Self-Testing for HIV in Blantyre, Malawi: A Community-Based Prospective Study
Choko, A. T., MacPherson, P., Webb, E. L., Willey, B., Feasey, H. R. A., Sambakunsi, R., Mdolo, A., Makombe, S. D., Desmond, N., Hayes, R., et al. (2015) · PLoS Medicine · doi:10.1371/journal.pmed.1001873 · Cited by 339
Past, present and future: 30 years of HIV research
Barré‐Sinoussi, F., Ross, A. L., & Delfraissy, J. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3132 · Cited by 387
From non-A, non-B hepatitis to hepatitis C virus cure
Pawlotsky, J., Feld, J. J., Zeuzem, S., & Hoofnagle, J. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.006 · Cited by 328
HIV TransmissionPreprint
Shaw, G. M., & Hunter, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006965 · Cited by 383
Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades
Levi, J., Raymond, A., Pozniak, A., Vernazza, P., Kohler, P. P., & Hill, A. (2016) · BMJ Global Health · doi:10.1136/bmjgh-2015-000010 · Cited by 327
What Drives the US and Peruvian HIV Epidemics in Men Who Have Sex with Men (MSM)?
Goodreau, S. M., Carnegie, N. B., Vittinghoff, E., Lama, J. R., Sánchez, J., Grinsztejn, B. G. J., Koblin, B. A., Mayer, K. H., & Buchbinder, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050522 · Cited by 331
Self-citation
The DREAMS core package of interventions: A comprehensive approach to preventing HIV among adolescent girls and young women
Saul, J. R., Bachman, G. L., Allen, S., Toiv, N., Cooney, C., & Beamon, T. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208167 · Cited by 324
A Systematic Review of Recent Smartphone, Internet and Web 2.0 Interventions to Address the HIV Continuum of Care
Muessig, K. E., Nekkanti, M., Bauermeister, J. A., Bull, S. S., & Hightow‐Weidman, L. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0239-3 · Cited by 329
Building Research Capacity in Africa: Equity and Global Health Collaborations
Chu, K., Jayaraman, S., Kyamanywa, P., & Ntakiyiruta, G. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001612 · Cited by 320
Voluntary Medical Male Circumcision: Modeling the Impact and Cost of Expanding Male Circumcision for HIV Prevention in Eastern and Southern Africa
Njeuhmeli, E., Forsythe, S., Reed, J. B., Opuni, M., Bollinger, L. A., Heard, N., Castor, D., Stover, J., Farley, T. M. M., Menon, V. P., et al. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001132 · Cited by 320
Tenofovir, Emtricitabine, and Tenofovir Diphosphate in Dried Blood Spots for Determining Recent and Cumulative Drug Exposure
Castillo‐Mancilla, J., Zheng, J., Rower, J. E., Meditz, A. L., Gardner, E. M., Predhomme, J. A., Fernandez, C., Langness, J. A., Kiser, J. J., Bushman, L. R., et al. (2012) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2012.0089 · Cited by 314
The Impact of Anticipated HIV Stigma on Delays in HIV Testing Behaviors: Findings from a Community-Based Sample of Men Who Have Sex with Men and Transgender Women in New York City
Golub, S. A., & Gamarel, K. E. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2013.0245 · Cited by 314
No Perinatal HIV-1 Transmission From Women With Effective Antiretroviral Therapy Starting Before Conception
Mandelbrot, L., Tubiana, R., Chenadec, J. L., Dollfus, C., Faye, A., Pannier, E., Matheron, S., Khuong, M.-A., Garrait, V., Reliquet, V., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ578 · Cited by 308
HIV
Ghosn, J., Taiwo, B., Seedat, S., Autran, B., & Katlama, C. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31311-4 · Cited by 332
Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1–Serodiscordant Couples
Hughes, J. P., Baeten, J. M., Lingappa, J. R., Magaret, A., Wald, A., de Bruyn, G., Kiarie, J. N., Inambao, M., Kilembe, W., Farquhar, C., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir747 · Cited by 304
HIV treatment as prevention and HPTN 052
Cohen, M. S., McCauley, M., & Gamble, T. (2012) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32834f5cf2 · Cited by 301
Self-citation
Regression Discontinuity Designs in Epidemiology: Causal Inference Without Randomized Trials
Bor, J., Moscoe, E., Mutevedzi, P., Newell, M.-L., & Bärnighausen, T. (2014) · Epidemiology · doi:10.1097/ede.0000000000000138 · Cited by 291
Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention
van der Straten, A., Damme, L. V., Haberer, J. E., & Bangsberg, D. R. (2012) · AIDS · doi:10.1097/qad.0b013e3283522272 · Cited by 302
Defeating AIDS—advancing global health
Piot, P., Abdool Karim, S. S., Hecht, R., Legido-Quigley, H., Buse, K., Stover, J., Resch, S., Ryckman, T., Møgedal, S., Dybul, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60658-4 · Cited by 293
Global and regional trends of people living with HIV aged 50 and over: Estimates and projections for 2000–2020
Autenrieth, C. S., Beck, E. J., Stelzle, D., Mallouris, C., Mahy, M. I., & Ghys, P. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207005 · Cited by 287
HIV transmission rates from persons living with HIV who are aware and unaware of their infection
Hall, H. I., Holtgräve, D. R., & Maulsby, C. H. (2012) · AIDS · doi:10.1097/qad.0b013e328351f73f · Cited by 291
Prospective study of acute HIV-1 infection in adults in East Africa and Thailand.
Robb, M. L., Eller, L. A., Kibuuka, H., Rono, K., Maganga, L., Nitayaphan, S., Kroon, E., Sawe, F. K., Sinei, S., Sriplienchan, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1508952 · Cited by 283
Profile: The KEMRI/CDC Health and Demographic Surveillance System—Western Kenya
Odhiambo, F. O., Laserson, K. F., Sewe, M., Hamel, M. J., Feikin, D. R., Adazu, K., Ogwang, S., Obor, D., Amek, N., Bayoh, N., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dys108 · Cited by 271
Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial
Masters, S. H., Agot, K. E., Obonyo, B., Napierala, S., Maman, S., & Thirumurthy, H. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002166 · Cited by 276
Measuring Retention in HIV Care
Mugavero, M. J., Westfall, A. O., Zinski, A., Davila, J. A., Drainoni, M., Gardner, L. I., Keruly, J. C., Malitz, F. E., Marks, G. N., Metsch, L. R., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318273762f · Cited by 270
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort
Tanner, Z., Lachowsky, N. J., Ding, E., Samji, H., Hull, M., Cescon, A., Patterson, S., Chia, J., Leslie, A., Raboud, J., et al. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1926-z · Cited by 268
The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis
Iroh, P. A., Mayo, H., & Nijhawan, A. E. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302635 · Cited by 263
A Review of the Role of Food Insecurity in Adherence to Care and Treatment Among Adult and Pediatric Populations Living with HIV and AIDS
Young, S. L., Wheeler, A. C., McCoy, S. I., & Weiser, S. D. (2013) · AIDS and Behavior · doi:10.1007/s10461-013-0547-4 · Cited by 263
Impact of Geographic and Transportation-Related Barriers on HIV Outcomes in Sub-Saharan Africa: A Systematic Review
Lankowski, A. J., Siedner, M. J., Bangsberg, D. R., & Tsai, A. C. (2014) · AIDS and Behavior · doi:10.1007/s10461-014-0729-8 · Cited by 261
Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples
Anglemyer, A. T., Rutherford, G. W., Horváth, H., Baggaley, R. C., Egger, M., & Siegfried, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009153.pub3 · Cited by 259
A call to action for comprehensive HIV services for men who have sex with men
Beyrer, C., Sullivan, P. S., Sánchez, J., Dowdy, D. W., Altman, D., Trapence, G., Collins, C., Katabira, E. T., Kazatchkine, M. D., Sidibé, M., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61022-8 · Cited by 254
Self-citation
The evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future
Tseng, A. L.-I., Seet, J., & Phillips, E. J. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12403 · Cited by 263
HIV Preexposure Prophylaxis
Riddell, J., Amico, K. R., & Mayer, K. H. (2018) · JAMA · doi:10.1001/jama.2018.1917 · Cited by 265
Self-citation
Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America
Thompson, M., Horberg, M. A., Agwu, A. L., Colasanti, J. A., Jain, M. K., Short, W. R., Singh, T., & Aberg, J. A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1391 · Cited by 269
Health Care Provider Barriers to HIV Pre-Exposure Prophylaxis in the United States: A Systematic Review
Pleuhs, B., Quinn, K. G., Walsh, J. L., Petroll, A. E., & John, S. A. (2020) · AIDS Patient Care and STDs · doi:10.1089/apc.2019.0189 · Cited by 260
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here?
Cohen, M. S., Smith, M. K., Muessig, K. E., Hallett, T. B., Powers, K. A., & Kashuba, A. D. M. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61998-4 · Cited by 257
Self-citation
Racial and Ethnic Disparities in Reproductive Health Services and Outcomes, 2020
Sutton, M. Y., Anachebe, N. F., Lee, R., & Skanes-DeVold, H. (2021) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000004224 · Cited by 278
Maximising the effect of combination HIV prevention through prioritisation of the people and places in greatest need: a modelling study
Anderson, S., Cherutich, P., Kilonzo, N., Cremin, Í., Fecht, D., Kimanga, D. O., Harper, M., Masha, R. L., Ngongo, B. P., Maina, W. K., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61053-9 · Cited by 250

Authors: Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., Godbole, S. V., Mehendale, S., Chariyalertsak, S., Santos, B. R., Mayer, K. H., Hoffman, I. F., Eshleman, S. H., Piwowar-Manning, E., Wang, L., Makhema, J., Mills, L. A., de Bruyn, G., Sanne, I., Eron, J., Gallant, J., Havlir, D., Swindells, S., Ribaudo, H., Elharrar, V., Burns, D., Taha, T. E., Nielsen-Saines, K., Celentano, D., Essex, M., & Fleming, T. R.
Affiliations: University of North Carolina at Chapel Hill (US)
Fred Hutch Cancer Center (US)
YR Gaitonde Centre for AIDS Research and Education (IN)
University of Zimbabwe (ZW)
Johns Hopkins University (US)
National AIDS Research Institute (IN)
Chiang Mai University (TH)
Fenway Health (US)
Harvard University (US)
Kenya Medical Research Institute (KE)
University of California, San Francisco (US)
University of Nebraska Medical Center (US)
National Institutes of Health (US)
University of Washington (US)
ORCID: Cohen, Myron S.
Chen, Ying Q.
Gamble, Theresa
Hosseinipour, Mina C.
Kumarasamy, Nagalingeswaran
Hakim, James G.
Kumwenda, Johnstone
Grinsztejn, Beatriz
Godbole, Sheela V.
Mehendale, Sanjay
Chariyalertsak, Suwat
Santos, Breno R.
Mayer, Kenneth H.
Hoffman, Irving F.
Eshleman, Susan H.
Wang, Lei
Makhema, Joseph
Mills, Lisa A.
Sanne, Ian
Eron, Joseph
Gallant, Joel
Havlir, Diane
Swindells, Susan
Ribaudo, Heather
Burns, David
Taha, Taha E.
Celentano, David
Essex, Max
Fleming, Thomas R.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2011-08-11
Volume: 365
Issue: 6
Pages: 493-505
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa1105243
PMC: PMC3200068
OpenAlex: W2152505869
Cited by: 6,873
References: 35
Citations by year: 2026: 106 · 2025: 155 · 2024: 189 · 2023: 204 · 2022: 288 · 2021: 354 · 2020: 398 · 2019: 471 · 2018: 510 · 2017: 594 · 2016: 694 · 2015: 720 · 2014: 759 · 2013: 740 · 2012: 571
FWCI: 466.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
Funders: Abbott Laboratories
Bristol-Myers Squibb
Pfizer
GlaxoSmithKline
Sanofi
Gilead Sciences
ViiV Healthcare
Abbott Diagnostics
Sanofi Pasteur
National Institute of Allergy and Infectious Diseases (U01AI068617, U01AI068619, U01AI068613, K24AI051982, UM1AI068619, UM1AI069418, P30AI050410, UM1AI068613, UM1AI068617, P30AI027763)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042854)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
Keywords: HIV-1 prevention, early antiretroviral therapy, serodiscordant couples, sexual transmission of HIV, CD4 count, HIV-negative partners, tuberculosis, bacterial infection, AIDS mortality, HPTN 052
MeSH terms: Adolescent, Adult, Drug Therapy, Combination, Female, HIV Seropositivity, Humans, Male, Sexual Partners, HIV-1, HIV Infections, Proportional Hazards Models, Treatment Outcome, Disease Progression, Spouses, Disease Transmission, Infectious, Anti-Retroviral Agents, Kaplan-Meier Estimate, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of HIV-1 infection with early antiretroviral therapy.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks